pamidronate has been researched along with Emesis in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intravenous injection of 4 mg zoledronic acid can significantly reduce bone pain and bone resorption marker in urine in the Chinese patients with bone metastasis from solid tumor or multiple myeloma, which is tolerable and also comparable to pamidronate in the efficacy and safety." | 9.13 | [Phase III clinical study of zoledronic acid in the treatment of pain induced by bone metastasis from solid tumor or multiple myeloma]. ( Chen, Q; Dong, M; Feng, FY; Feng, JF; Jiao, SC; Li, J; Liu, JW; Ren, J; Song, ST; Wang, XW; Wang, YJ; Wang, ZH; Xie, GR; Xu, N; Zhang, Y; Zhou, QH, 2008) |
| "47 patients with progressive, painful, predominantly lytic bone metastases from breast cancer were included in a randomised double-blind phase II trial comparing the effects of pamidronate 150 and 300 mg daily." | 9.08 | A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer. ( Coleman, RE; Ford, J; Houston, S; Kandra, A; Purohit, OP; Rubens, RD, 1998) |
| "Intravenous injection of 4 mg zoledronic acid can significantly reduce bone pain and bone resorption marker in urine in the Chinese patients with bone metastasis from solid tumor or multiple myeloma, which is tolerable and also comparable to pamidronate in the efficacy and safety." | 5.13 | [Phase III clinical study of zoledronic acid in the treatment of pain induced by bone metastasis from solid tumor or multiple myeloma]. ( Chen, Q; Dong, M; Feng, FY; Feng, JF; Jiao, SC; Li, J; Liu, JW; Ren, J; Song, ST; Wang, XW; Wang, YJ; Wang, ZH; Xie, GR; Xu, N; Zhang, Y; Zhou, QH, 2008) |
| "47 patients with progressive, painful, predominantly lytic bone metastases from breast cancer were included in a randomised double-blind phase II trial comparing the effects of pamidronate 150 and 300 mg daily." | 5.08 | A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer. ( Coleman, RE; Ford, J; Houston, S; Kandra, A; Purohit, OP; Rubens, RD, 1998) |
| "Glucocorticoids may be used as primary treatment when hypercalcemia is due to excessive intestinal calcium absorption (vitamin D intoxication, granulomatous disorders, some lymphomas)." | 2.82 | Hypercalcemia: A Review. ( Shane, E; Walker, MD, 2022) |
| "Osteoporosis is a common complication in children with motor impairments." | 1.37 | Tolerance and effectiveness on pain control of Pamidronate® intravenous infusions in children with neuromuscular disorders. ( Berard, C; Poirot, I; Vuillerot, C; Wagner, S, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Walker, MD | 1 |
| Shane, E | 1 |
| Dong, M | 1 |
| Feng, FY | 1 |
| Zhang, Y | 1 |
| Xie, GR | 1 |
| Wang, YJ | 1 |
| Liu, JW | 1 |
| Song, ST | 1 |
| Zhou, QH | 1 |
| Ren, J | 1 |
| Jiao, SC | 1 |
| Li, J | 1 |
| Wang, XW | 1 |
| Chen, Q | 1 |
| Wang, ZH | 1 |
| Xu, N | 1 |
| Feng, JF | 1 |
| Wagner, S | 1 |
| Poirot, I | 1 |
| Vuillerot, C | 1 |
| Berard, C | 1 |
| Sleeboom, HP | 1 |
| Bijvoet, OL | 1 |
| Coleman, RE | 1 |
| Houston, S | 1 |
| Purohit, OP | 1 |
| Rubens, RD | 1 |
| Kandra, A | 1 |
| Ford, J | 1 |
| Frye, D | 1 |
| Kowalski, MO | 1 |
1 review available for pamidronate and Emesis
| Article | Year |
|---|---|
Hypercalcemia: A Review.
Topics: Calcium; Coma; COVID-19; Dehydration; Denosumab; Humans; Hypercalcemia; Hyperparathyroidism, Primary | 2022 |
2 trials available for pamidronate and Emesis
| Article | Year |
|---|---|
[Phase III clinical study of zoledronic acid in the treatment of pain induced by bone metastasis from solid tumor or multiple myeloma].
Topics: Adult; Aged; Analgesics; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Collage | 2008 |
A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Breast | 1998 |
3 other studies available for pamidronate and Emesis
| Article | Year |
|---|---|
Tolerance and effectiveness on pain control of Pamidronate® intravenous infusions in children with neuromuscular disorders.
Topics: Adolescent; Analgesics; Bone Density Conservation Agents; Child; Diphosphonates; Drug Evaluation; Fe | 2011 |
Hypercalcaemia due to malignancy. Role of the kidney and treatment.
Topics: Calcitonin; Calcium; Diphosphonates; Extracellular Space; Fluid Therapy; Glomerular Filtration Rate; | 1982 |
Readers question whether drug increases side effects of chemotherapy.
Topics: Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Diphosphonates; Drug Monitoring; D | 1999 |